ATP2C1 gene mutations in Hailey–Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking

• Published in: Cell death & disease 2016-06, Vol.7 (6), p.e2259-e2259
• Main Authors: Micaroni, M, Giacchetti, G, Plebani, R, Xiao, G G, Federici, L
• Format: Article
• Language: English
• Subjects: 38/23; 45/43; 631/208/2489/144; 631/208/737; 631/80/313; 692/699; 82/75; Animals; Antibodies; Biochemistry; Biomedical and Life Sciences; Calcium-Transporting ATPases - chemistry; Calcium-Transporting ATPases - genetics; Calcium-Transporting ATPases - metabolism; Cell Biology; Cell Culture; Cell Membrane - metabolism; Genetics; Humans; Immunology; Isoenzymes - chemistry; Isoenzymes - genetics; Isoenzymes - metabolism; Keratinocytes - enzymology; Life Sciences; Membranes; Mutation; Mutation - genetics; Pemphigus, Benign Familial - enzymology; Pemphigus, Benign Familial - genetics; Protein Transport; Proteins; Review
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/cddis.2016.147

ATP2C1 gene codes for the secretory pathway Ca 2+ /Mn 2+ -ATPase pump type 1 (SPCA1) localizing at the golgi apparatus. Mutations on the human ATP2C1 gene, causing decreased levels of the SPCA1 expression, have been identified as the cause of the Hailey–Hailey disease, a rare skin disorder. In the last few years, several mutations have been described, and here we summarize how they are distributed along the gene and how missense mutations affect protein expression. SPCA1 is expressed in four different isoforms through alternative splicing of the ATP2C1 gene and none of these isoforms is differentially affected by any of these mutations. However, a better understanding of the tissue specific expression of the isoforms, their localization along the secretory pathway, their specific binding partners and the role of the C-terminal tail making isoforms different from each other, will be future goals of the research in this field.